Research Summary
Research Summary
03/31/2023

Anthony Calabro, MA

Anthony Calabro, MA
Researchers determined the impact of melanoma subtypes on cutaneous immune-related adverse events and survival among those who received immune checkpoint inhibitor therapy.
03/31/2023
Research Summary
Research Summary
02/23/2023
The American Heart Association (AHA) addresses the adverse effect of hypertension in patients receiving anticancer therapies and how the disease should be managed.
02/23/2023
Research Summary
Research Summary
02/01/2023
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
02/01/2023
Bladder Cancer
Bladder Cancer
01/04/2023
The FDA’s approval of the first gene therapy to treat high-risk non-muscle-invasive bladder cancer follow a multicenter clinical trial.
01/04/2023
Metastatic Lung Cancer
Metastatic Lung Cancer
12/07/2022
The FDA-approved treatment combines tremelimumab, durvalumab, and platinum-based chemotherapy, and follows a randomized trial.
12/07/2022
Inflammatory Breast Cancer
Inflammatory Breast Cancer
10/12/2022
Researchers find that people diagnosed with a rare subtype of breast cancer are at a high risk of cancer spreading to their brains.
10/12/2022
Cancer Pain
Cancer Pain
09/28/2022
The recommendations include effective forms of therapy to help manage common symptoms associated with cancer such as joint pain.
09/28/2022
Insulin Management
Insulin Management
08/04/2022
A higher incidence of certain cancers has been previously reported among individuals with type 1 diabetes. In this study, researchers examined daily insulin dosages as a potential risk factor for cancer...
08/04/2022
nutrition
nutrition
07/05/2022
The USPSTF has updated its recommendations on the use of vitamins and dietary supplements for the prevention of cardiovascular disease or cancer.
07/05/2022
Screening
Screening
06/30/2022
In a new study, investigators examined the impact of the expanded lung cancer screening criteria on the mortality rate of high-risk patient populations.
06/30/2022